| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 1.116 | 0 | 0 | 88.530 | 100.779 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 1.116 | 0 | 0 | 88.530 | 100.799 |
| Total Expenses - EUR | 0 | 0 | 0 | 847 | 759 | 675 | 445 | 2.430 | 13.184 | 33.825 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | -847 | -759 | 441 | -445 | -2.430 | 75.346 | 66.974 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | -847 | -759 | 411 | -445 | -2.430 | 74.614 | 64.011 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Aneradmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 912 | 903 | 887 | 384 | 192 | 0 | 0 | 0 | 0 | 68.933 |
| Current Assets | 237 | 234 | 231 | 226 | 226 | 223 | 213 | 8 | 68.391 | 50.876 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 237 | 234 | 231 | 226 | 222 | 218 | 213 | 0 | 51.915 | 50.476 |
| Cash | 0 | 0 | 0 | 0 | 4 | 5 | 0 | 8 | 16.476 | 400 |
| Shareholders Funds | -4.745 | -4.696 | -4.617 | -5.377 | -6.032 | -5.507 | -5.830 | -8.278 | 66.361 | 63.137 |
| Social Capital | 45 | 45 | 44 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 6.073 | 6.011 | 5.909 | 6.158 | 6.618 | 5.894 | 6.204 | 8.448 | 2.303 | 56.914 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Aneradmed S.r.l.